HealthTech Media Room - Health Technology Insights - Page 339

HealthTech Media Room

Final Rounds of Late-Breaking Clinical Trial Results Announced at VIVA24

January 2, 2025

Two Data Analyses From Clinical Trials Show Epcoritamab Induces Durable Complete Reponses

January 2, 2025

HKBU’s Aptamer for X-Linked Hypophosphatemia Receives Orphan Drug Status

January 2, 2025

Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu

January 2, 2025

Oncolytics Biotech Highlights 2024 Milestones, Prepares for 2025

January 2, 2025

NeuroSense Therapeutics Enters Binding Term Sheet to Advance PrimeC for ALS

January 2, 2025

Sumitomo Pharma America Announces FDA Approval of GEMTESA for Overactive Bladder

January 2, 2025

Keymed Biosciences Announces Approval Of Stapokibart For The Treatment Of Chronic Rhinosinusitis With Nasal Polyposis

Keymed Biosciences Announces Approval of Stapokibart for Chronic Rhinosinusitis

January 2, 2025

How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

January 2, 2025

Ractigen Therapeutics Announces First Patient Dosed in Phase I Clinical Trial for RAG-17 in SOD1-ALS

Ractigen Therapeutics Doses First Patient in Phase I Trial for RAG-17 in SOD1-ALS

December 27, 2024

Preliminary Results of Qilu Pharmaceutical’s Phase Ia Study on GPRC5DCD3-Targeting Bispecific Antibody QLS32015

Qilu Pharmaceutical Reports Preliminary Results of Phase Ia Study on QLS32015

December 26, 2024

Microtech Announces First Human Case of Implantable Microsensor for Heart Failure

Microtech Announces First Human Case of Implantable Microsensor for Heart Failure

December 26, 2024